Onur Eşbah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Onur Eşbah has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Sinem Kantarcıoğlu Coşkun
Duzce Universitesi
2 shared publications - Ali Ümit Eşbah
Duzce Universitesi
1 shared publication - Attila Onmez
Department of Internal Medicine, Faculty of Medicine, Duzce University, 81000 Duzce, Türkiye
1 shared publication - Ayhan Öztürk
Düzce University Department of Neurology, School of Medicine, Düzce University, Düzce, Türkiye
1 shared publication - Birgül Öneç
Düzce Üniversitesi Tıp Fakültesi, Hematoloji Bilim Dalı, Düzce, Türkiye
1 shared publication - Ethem Şahin
Department of Medical Biochemistry, Faculty of Medicine, Düzce University, Düzce 81620, Türkiye
1 shared publication
Latest Publications
- 29 June 2022
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 14 (2) , 424-428
Paraneoplastic Severe Sensorimotor Axonal Polyneuropathy in Pancreatic Neuroendocrine Carcinoma: A Case Report and Review Of The Literature
Objective: Paraneoplastic neurological syndromes (PNSs) are a diverse group of neurological disorders affecting any part of the nervous system before or during cancer. Case: A 78-year-old patient had pain and burning sensation first in the upper extremity 3 years ago, and then, muscle weakness was added a short time later. The same symptoms developed in the lower extremities 1 year ago. He was admitted to the intensive care unit due to pneumonia and was conscious but quadriplegic with a modified Rankin score of 5. Abdominal computed tomography showed mass lesions in the liver and pancreas. The biopsies demonstrated pancreatic small cell neuroendocrine carcinoma. Electrophysiological studies disclosed severe sensorimotor axonal polyneuropathy. Since other polyneuropathy causes were excluded, the diagnosis was paraneoplastic sensorimotor axonal polyneuropathy. Palliative care was considered because the patient had a poor functional state. Conclusion: Early cancer diagnosis is paramount in patients with PNSs to have appropriate therapy.
- 29 June 2022
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 14 (2) , 424-428
Paraneoplastic Severe Sensorimotor Axonal Polyneuropathy in Pancreatic Neuroendocrine Carcinoma: A Case Report and Review Of The Literature
Objective: Paraneoplastic neurological syndromes (PNSs) are a diverse group of neurological disorders affecting any part of the nervous system before or during cancer. Case: A 78-year-old patient had pain and burning sensation first in the upper extremity 3 years ago, and then, muscle weakness was added a short time later. The same symptoms developed in the lower extremities 1 year ago. He was admitted to the intensive care unit due to pneumonia and was conscious but quadriplegic with a modified Rankin score of 5. Abdominal computed tomography showed mass lesions in the liver and pancreas. The biopsies demonstrated pancreatic small cell neuroendocrine carcinoma. Electrophysiological studies disclosed severe sensorimotor axonal polyneuropathy. Since other polyneuropathy causes were excluded, the diagnosis was paraneoplastic sensorimotor axonal polyneuropathy. Palliative care was considered because the patient had a poor functional state. Conclusion: Early cancer diagnosis is paramount in patients with PNSs to have appropriate therapy.
- Open Access
- 7 June 2021
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 13 (2) , 211-217
Type and level of anxiety affects the perception of pain during bone marrow biopsy
Objective: Bone marrow aspiration and biopsy (BMAB) is an essential tool for the diagnosis of hematological disorders. The most frequent complaint after BMAB is pain but the severity of this pain is described very different among patients. We investigated factors predicting this pain focusing on the role of state and trait anxiety. Methods: One hundred and ten adult patients undergoing BMAB, were informed adequately and assessed with “The State-Trait Anxiety Inventory” (STAI) before the procedure. In this Likert-type inventory, State Anxiety Scale evaluates the current state of anxiety, asking how respondents feel “at that moment”. The Trait Anxiety Scale evaluates relatively stable aspects of “anxiety proneness,” including general states of confidence, calmness, and security. After the biopsy, the pain was measured with visual analog scale. Results: Most of the patients (71.8%) described mild pain but moderate to severe pain were significantly more frequent in both high state and trait anxiety groups. Pain severity had a positive but weak correlation with trait anxiety but not with state anxiety. The described pain level was associated with older age but was not with an indication of biopsy, performance status, comorbidities or previous BMAB experiences. Conclusion: Results of our study made us thought that a good communication with the patient and talking about possible outcomes days before procedure might play a role in reducing his or her anxiety but because age and trait anxiety cannot be changed by using fast-acting anxiolytic drugs, the advantage of premedication with anxiolytics in order of reducing pain, would be limited.
- 7 June 2021
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 13 (2) , 211-217
Open AccessType and level of anxiety affects the perception of pain during bone marrow biopsy
Objective: Bone marrow aspiration and biopsy (BMAB) is an essential tool for the diagnosis of hematological disorders. The most frequent complaint after BMAB is pain but the severity of this pain is described very different among patients. We investigated factors predicting this pain focusing on the role of state and trait anxiety. Methods: One hundred and ten adult patients undergoing BMAB, were informed adequately and assessed with “The State-Trait Anxiety Inventory” (STAI) before the procedure. In this Likert-type inventory, State Anxiety Scale evaluates the current state of anxiety, asking how respondents feel “at that moment”. The Trait Anxiety Scale evaluates relatively stable aspects of “anxiety proneness,” including general states of confidence, calmness, and security. After the biopsy, the pain was measured with visual analog scale. Results: Most of the patients (71.8%) described mild pain but moderate to severe pain were significantly more frequent in both high state and trait anxiety groups. Pain severity had a positive but weak correlation with trait anxiety but not with state anxiety. The described pain level was associated with older age but was not with an indication of biopsy, performance status, comorbidities or previous BMAB experiences. Conclusion: Results of our study made us thought that a good communication with the patient and talking about possible outcomes days before procedure might play a role in reducing his or her anxiety but because age and trait anxiety cannot be changed by using fast-acting anxiolytic drugs, the advantage of premedication with anxiolytics in order of reducing pain, would be limited.
- 20 October 2020
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 12 (3) , 519-524
Meme kanserli hastalarda serum Seladin-1/DHCR24 düzeyinin araştırılması
Amaç: Meme kanseri kadınlarda önemli bir morbidite ve mortalite nedenidir. Desmosterolden kolesterol oluşum reaksiyonunu katalizleyen enzim olan Seladin-1 daha önce çeşitli tümör türlerinde farklı düzeylerde exprese edildiği gözlenmiştir. Çalışmamızda; serum seladin-1 düzeyleri ile metastatik olmayan meme kanseri hastalarının klinik özellikleri arasındaki ilişkiyi ve seladin-1'in meme kanserinde prognostik değerini araştırmayı amaçladık. Gereç ve yöntem: Tıbbi onkoloji kliniğimizde, 18 yaş üstü, histopatolojik olarak meme kanseri tanısı almış, cerrahi olarak tümör dokusu çıkarılmış, herhangi bir onkolojik tedavi henüz almamış, uzak organ metastazı ve ek malignitesi olmayan hastalar ile kontrol grubu olarak sağlıklı kadın gönüller çalışmaya dahil edildi. Demografik veriler ve laboratuvar verileri kaydedildi. Serum seladin-1 düzeyleri hasta ve kontrol grupları arasında karşılaştırıldı. Bulgular: 46 hasta ve 27 kontrol grubu olmak üzere toplam 73 kadın hasta çalışmaya dahil edildi. Hasta grubunun yaş ortalaması 56±12 yıl, kontrol grubunun 62±12 yıldı (p=0.055) Seladin-1 düzeyleri gruplar arasında karşılaştırıldığında; hasta grubunda kontrol grubuna göre daha düşük seviyede saptandı (0.28461±0.10181 vs 0.40530±0.15130 ng/ml; p=0.038). Tümör boyutları ile Seladin-1 düzeyi arasında istatistiksel bir ilişki yoktu. (p=0.138). Bunun yanında, hastaların stagelerine göre seladin-1 düzeyi karşılaştırıldığında istatistiksel fark olmadığı görüldü (p=0,720; p=0,092, sırasıyla). Sonuç: Çalışmamızda meme kanseri hastalarının serumlarında seladin-1 düzeyi kontrol grubuna göre daha düşük saptandı. Ne var ki, meme kanserinin prognostik faktörleri ile seladin-1 düzeylerinin ilişkili olmadığı görülmüştür. Seladin-1’in meme kanserli hastalarında düşük olmasının altında yatan mekanizmaların aydınlatılabilmesi için daha ileri araştırmalar gerekmektedir.
- 20 October 2020
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 12 (3) , 519-524
Meme kanserli hastalarda serum Seladin-1/DHCR24 düzeyinin araştırılması
Amaç: Meme kanseri kadınlarda önemli bir morbidite ve mortalite nedenidir. Desmosterolden kolesterol oluşum reaksiyonunu katalizleyen enzim olan Seladin-1 daha önce çeşitli tümör türlerinde farklı düzeylerde exprese edildiği gözlenmiştir. Çalışmamızda; serum seladin-1 düzeyleri ile metastatik olmayan meme kanseri hastalarının klinik özellikleri arasındaki ilişkiyi ve seladin-1'in meme kanserinde prognostik değerini araştırmayı amaçladık. Gereç ve yöntem: Tıbbi onkoloji kliniğimizde, 18 yaş üstü, histopatolojik olarak meme kanseri tanısı almış, cerrahi olarak tümör dokusu çıkarılmış, herhangi bir onkolojik tedavi henüz almamış, uzak organ metastazı ve ek malignitesi olmayan hastalar ile kontrol grubu olarak sağlıklı kadın gönüller çalışmaya dahil edildi. Demografik veriler ve laboratuvar verileri kaydedildi. Serum seladin-1 düzeyleri hasta ve kontrol grupları arasında karşılaştırıldı. Bulgular: 46 hasta ve 27 kontrol grubu olmak üzere toplam 73 kadın hasta çalışmaya dahil edildi. Hasta grubunun yaş ortalaması 56±12 yıl, kontrol grubunun 62±12 yıldı (p=0.055) Seladin-1 düzeyleri gruplar arasında karşılaştırıldığında; hasta grubunda kontrol grubuna göre daha düşük seviyede saptandı (0.28461±0.10181 vs 0.40530±0.15130 ng/ml; p=0.038). Tümör boyutları ile Seladin-1 düzeyi arasında istatistiksel bir ilişki yoktu. (p=0.138). Bunun yanında, hastaların stagelerine göre seladin-1 düzeyi karşılaştırıldığında istatistiksel fark olmadığı görüldü (p=0,720; p=0,092, sırasıyla). Sonuç: Çalışmamızda meme kanseri hastalarının serumlarında seladin-1 düzeyi kontrol grubuna göre daha düşük saptandı. Ne var ki, meme kanserinin prognostik faktörleri ile seladin-1 düzeylerinin ilişkili olmadığı görülmüştür. Seladin-1’in meme kanserli hastalarında düşük olmasının altında yatan mekanizmaların aydınlatılabilmesi için daha ileri araştırmalar gerekmektedir.
- Open Access
- 1 January 2020
- Published by Galenos Yayinevi in Acta Oncologica Turcica
- Vol. 53 (1) , 151-154
A Rare Case of Rectal Cancer With Endometrial Metastasis: A Case Report
- 1 January 2020
- Published by Galenos Yayinevi in Acta Oncologica Turcica
- Vol. 53 (1) , 151-154
Open AccessA Rare Case of Rectal Cancer With Endometrial Metastasis: A Case Report